Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care

被引:50
作者
Seguin, Philippe [1 ]
Fedun, Yannick [1 ]
Laviolle, Bruno [2 ,3 ]
Nesseler, Nicolas [1 ]
Donnio, Pierre-Yves [4 ]
Malledant, Yannick [1 ]
机构
[1] Univ Rennes 1, Serv Reanimat Chirurg, INSERM U991, Hop Pontchaillou, F-35033 Rennes 9, France
[2] Hop Pontchaillou, Serv Pharmacol Clin, F-35033 Rennes 9, France
[3] Hop Pontchaillou, Ctr Invest Clin, INSERM 0203, F-35033 Rennes 9, France
[4] Hop Pontchaillou, Lab Bacteriol Virol, F-35033 Rennes 9, France
关键词
antimicrobial therapy; empirical therapy; in vitro susceptibility; surgery; VENTILATOR-ASSOCIATED PNEUMONIA; CONSENSUS CONFERENCE; INFECTIONS; EMERGENCE; OUTCOMES; FRANCE; IMPACT;
D O I
10.1093/jac/dkp439
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This prospective non-interventional study investigated the risk factors for multidrug-resistant bacteria (MDRB) in patients with post-operative peritonitis (POP), to provide guidance for empirical antimicrobial therapy. All consecutive patients, > 15 years old, admitted to a surgical intensive care unit (ICU) between September 2006 and January 2009 for a first episode of POP were included. Antibiotic susceptibilities of microorganisms recovered from blood cultures and peritoneal fluid were determined by disc diffusion. Amoxicillin/clavulanic acid, ticarcillin/clavulanic acid, piperacillin/tazobactam, cefotaxime, ceftazidime, cefepime, imipenem, gentamicin, amikacin and ciprofloxacin were tested against Gram-negative bacteria, and oxacillin, amoxicillin, vancomycin, gentamicin and erythromycin were tested against aerobic Gram-positive bacteria. Results were reported as susceptible or resistant. MDRB were isolated from 20/115 (17%) patients. In univariate analysis, use of antimicrobial therapy during the 3 months prior to hospitalization and a long duration between hospital admission or first operation and relaparotomy were significantly associated with MDRB recovery. In multivariate analysis, only antimicrobial treatment in the 3 months preceding hospitalization and duration between first operation and relaparotomy were independent risk factors for MDRB [odds ratio (OR) = 5.80, 95% confidence interval (95% CI) = 1.99-16.91 and OR = 1.10, 95% CI = 1.02-1.19, respectively]. No MDRB were found when the delay between the first operation and relaparotomy was < 5 days. POP severity, non-surgical and surgical complications, hospital and ICU length of stay, and mortality were similar in patients with and without MDRB. Our results suggest that broad-spectrum antibiotics should be used in ICU patients with POP who have received antimicrobial therapy in the 3 months prior to hospitalization, or with > 5 days between the first operation and relaparotomy.
引用
收藏
页码:342 / 346
页数:5
相关论文
共 21 条
[2]  
Barie PS, 1997, ARCH SURG-CHICAGO, V132, P1294
[3]   Acute renal failure: time for consensus [J].
Bellomo, R ;
Kellum, J ;
Ronco, C .
INTENSIVE CARE MEDICINE, 2001, 27 (11) :1685-1688
[4]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[5]   Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study [J].
Bertrand, X. ;
Mouchot, L. ;
Jebabli, M. ;
Bajolet, O. ;
Aho, S. ;
Blech, M. -F. ;
Eloy, C. ;
Floret, N. ;
Gayet, S. ;
Talon, D. ;
Tronel, H. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (11) :1113-1117
[6]   THE ACCP-SCCM CONSENSUS CONFERENCE ON SEPSIS AND ORGAN FAILURE [J].
BONE, RC ;
SIBBALD, WJ ;
SPRUNG, CL .
CHEST, 1992, 101 (06) :1481-1482
[7]  
Christou NV, 1996, ARCH SURG-CHICAGO, V131, P1193
[8]   An antibiotic policy to prevent emergence of resistant bacilli [J].
de Man, P ;
Verhoeven, BAN ;
Verbrugh, HA ;
Vos, MC ;
van den Anker, JN .
LANCET, 2000, 355 (9208) :973-978
[9]   Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial [J].
Dupont, H ;
Carbon, C ;
Carlet, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2028-2033
[10]   VENTILATOR-ASSOCIATED PNEUMONIA - A MULTIVARIATE-ANALYSIS [J].
KOLLEF, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (16) :1965-1970